Jaina Razbek | Epidemiology | Best Scholar Award

Posted on by Pencis

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

✅ Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
✅ Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
✅ Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
✅ Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data" 

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study" 

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts" 

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome" 

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models" 

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Zafran Khan | Tuberculosis Researcher | Editorial Board Member

Posted on by Pencis

Mr. Zafran Khan | Tuberculosis | Editorial Board Member

University of Calgary | Pakisthan

Author Profile

Google Scholar

Orcid ID

EARLY ACADEMIC PURSUITS:

ZAFRAN KHAN initiated his academic journey at the University of Swat (UOS) in Swat, Pakistan, where he pursued a Bachelor of Science (Hons) in Microbiology from 2012 to 2016. During this period, he conducted research on the "Incidence of HCV in the general population of District Swat, Pakistan," showcasing an early interest in infectious diseases and molecular biology.

PROFESSIONAL ENDEAVORS:

Following his undergraduate studies, ZAFRAN KHAN ventured into higher education at the University of Chinese Academy of Sciences (UCAS) in Beijing, China. Here, he enrolled as a Master student in Biochemistry and Molecular Biology from September 2018 to August 2019. His coursework covered diverse topics, including Genomics, Immunology, Biochemistry, and Molecular Biology, laying a solid foundation for his subsequent research pursuits.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUBERCULOSIS

ZAFRAN KHAN's notable research contributions are evident during his tenure as a Master's Full-time Research Candidate at the State Key Laboratory of Respiratory Infectious Disease (GIBH) in Guangzhou, China, from August 2019 to August 2021. His primary research focus encompassed Mycobacterium tuberculosis resistance mechanisms, novel drug targets, docking, molecular dynamic simulation, and vaccine and drug designing. Noteworthy projects include the identification of resistance mechanisms associated with prothionamide and amikacin in Mycobacterium tuberculosis clinical isolates.

IMPACT AND INFLUENCE:

ZAFRAN KHAN's work holds significant implications for understanding and combating tuberculosis, a global health concern. His efforts in exploring unexplored resistance mechanisms and conducting molecular detection of anti-tubercular resistance in clinical isolates contribute to the broader scientific community's knowledge base. The impact of his research extends beyond borders, as evidenced by his involvement in international conferences and workshops.

ACADEMIC CITES:

ZAFRAN KHAN's academic journey is marked by a commitment to excellence, exemplified by his active participation in international conferences and workshops. This exposure has likely contributed to his knowledge enrichment and the incorporation of global perspectives into his research.

LEGACY AND FUTURE CONTRIBUTIONS:

ZAFRAN KHAN has established a legacy of dedication and proficiency in the field of Microbiology and Molecular Biology. His early research on HCV in Swat and subsequent work on tuberculosis resistance mechanisms showcase a commitment to addressing critical health challenges. As he progresses in his academic and research journey, ZAFRAN KHAN is poised to make further contributions to the scientific community, leaving a lasting legacy in the realm of infectious diseases and immunity.

Notable Publications

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?  2022(9)

Cold stress-induced seed germination and biosynthesis of polyphenolics content in medicinally important Brassica rapa 2022(8)

Chimeric antigen receptor T cell structure, its manufacturing, and related toxicities; a comprehensive review 2022(7)

Laura Warmke | Pathology | Best Researcher Award

Posted on by Pencis

Dr. Laura Warmke | Pathology | Best Researcher Award

University of Indiana School of Medicine | United States

Author Profile

Orcid ID

EARLY ACADEMIC PURSUITS:

During my undergraduate years from 2005 to 2009 at the University of Virginia, I pursued a Bachelor of Science in Chemistry with Distinction, accompanied by a Minor in Studio Art. This foundational period laid the groundwork for my multifaceted approach to learning, blending the analytical rigor of the sciences with the creative elements of studio art.

PROFESSIONAL ENDEAVORS:

In 2010, I embarked on the journey towards a Doctor of Medicine (M.D.) degree at the Virginia Commonwealth University School of Medicine in Richmond, VA. This phase of my education marked the transition from theoretical knowledge to the practical application of medical expertise, fostering my commitment to the field of pathology.

CONTRIBUTIONS AND RESEARCH FOCUS ON PATHOLOGY:

Throughout my residency at Virginia Commonwealth University Health System (2014-2017), I actively engaged in the field of Anatomic Pathology/Clinical Pathology (AP/CP), developing a keen interest in bone and soft tissue pathology. This interest led me to pursue specialized training, culminating in my Selective Bone & Soft Tissue Pathology Fellowship at The University of Texas MD Anderson Cancer Center in Houston, TX (2019-2020).

IMPACT AND INFLUENCE:

My role as the AP/CP Pathology Chief Resident at Virginia Commonwealth University Health System (2017-2018) allowed me to contribute significantly to the department's operations. I played a pivotal role in bridging clinical and anatomical aspects, fostering a comprehensive understanding of pathology.

ACADEMIC CITES:

In 2018, I achieved board certification in Anatomic Pathology/Clinical Pathology (AP/CP) from the American Board of Pathology, affirming my proficiency and dedication to maintaining the highest standards in the field.

LEGACY AND FUTURE CONTRIBUTIONS:

Since 2020, I have served as an Assistant Professor of Clinical Pathology & Laboratory Medicine at Indiana University School of Medicine. In this capacity, I continue to impart knowledge, mentor future pathologists, and contribute to the advancement of pathology through my clinical work and research endeavors.

HIGHLIGHTS:

My commitment to excellence is underscored by my continuous pursuit of knowledge and certifications, including my current Indiana Medical License (expiring 10/31/2025) and my status as a Basic Life Support (BLS) Provider certified by the American Heart Association.

FUTURE CONTRIBUTIONS:

Looking ahead, I am dedicated to furthering research, education, and patient care in the realm of pathology. I aspire to make enduring contributions to the field, leaving a lasting legacy through my dedication to excellence, mentorship, and continued pursuit of knowledge.

Notable publications:

Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma 2022(1)

“PRRX1-rearranged mesenchymal tumors”: expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature 2022(3)

NR1D1::MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature 2023(1)